Inhibition of translation of hepatitis C virus RNA by 2'-modified antisense oligonucleotides

Antisense and Nucleic Acid Drug Development

Volumn 9, Issue 2, 1999, Pages 145-154

  Brown Driver, Vickie ^a   Eto, Tatsuo ^b   Lesnik, Elena ^a   Anderson, Kevin P ^a   Hanecak, Ronnie C ^a,c  

^a ISIS PHARMACEUTICALS   (United States)

^b Kaketsuken   (Japan)

^c Trega Biosciences Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CORE PROTEIN; NUCLEASE; OLIGORIBONUCLEOTIDE; VIRUS RNA;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; ENZYME STABILITY; GENE EXPRESSION REGULATION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CELL; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; RABBIT; RETICULOCYTE LYSATE; RNA TRANSLATION;

ANIMALIA; HEPATITIS C VIRUS; ORYCTOLAGUS CUNICULUS;

EID: 0033000084     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1999.9.145     Document Type: Article

References (10)

1. AGRAWAL, S., IKEUCHI, T., SUN, D., SARIN, P.S., KONOPKA, A., MAIZEL, J., and ZAMECNIK, P.C. (1989). Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues. Proc. Natl. Acad. Sci. USA 86, 7790-7794.
2. ALT, M., RENZ, R., HOFSCHNEIDER, P.H., PAUMGARTNER, G., and CASELMANN, W.H. (1995). Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides. Hepatology 22, 707-717.
3. ALTMANN, K-H., DEAN, N.M., FABBRO, D., FREIER, S.M., GEIGER, T., HANER, R., HUSKEN, D., MARTIN, P., MONIA, B.P., MULLER, M., NATT, F., NICKLIN, P., PHILLIPS, J., PIELES, U., SASMOR, H., and MOSER, H.E. (1996). Second generation of antisense oligonucleotides: From nuclease resistance to biological efficacy in animals. Chimia 50, 168-176.
4. AZAD, R.F., DRIVER, V.B., TANAKA, K., CROOKE, R.M., and ANDERSON, K.P. (1993). Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region. Antimicrob. Agents Chemother. 37, 1945-1954.
5. BAKER, B.F., LOT, S.F., CONDON, T.P., CHENG-FLOURNOY, S., LESNIK, E., SASMOR, H.M., and BENNETT, C.F. (1997). 2′-O-(2-methoxy)ethyl modified anti-ICAM-1 oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in HUVECs. J. Biol. Chem. 272, 11994-12000.
6. BENNETT, C.F., CHIANG, M.-Y., CHAN, H., SHOEMAKER, J.E.E., and MIRABELLI, C.K. (1992). Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol. 41, 1023-1033.
7. BENNETT, C.F., CONDON, T., GRIMM, S., CHAN, H., and CHIANG, M.-Y. (1994). Inhibition of endothelial cell-leukocyte adhesion molecule expression with antisense oligonucleotides. J. Immunol. 152, 3530-3540.
8. BUKH, J., PURCELL, R.H., and MILLER, R.H. (1992). Sequence analysis of the 5′-noncoding region of hepatitis C virus. Proc. Natl. Acad. Sci. USA 89, 4942-4946.
9. BUKH, J., PURCELL, R.H., and MILLER, R.H. (1993). At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative El gene isolates collected worldwide. Proc. Natl. Acad. Sci. USA 90, 8234-8238.
10. CHIANG, M.-Y., CHAN, H., ZOUNES, M.A., FREIER, S.M., LIMA, W.F., and BENNETT, C.F. (1991). Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem. 266, 18162-18171.